Cargando…
COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma
Introduction: Tumor-treating fields (TTF) is an established modality for glioblastoma (GBM) treatment administered through the portable Optune system. The efficacy of Optune for newly diagnosed GBM was demonstrated in the EF-14 phase 3 trial. Although TTF is now included as part of initial treatment...
Autores principales: | Saito, Norihiko, Hirai, Nozomi, Sato, Sho, Hiramoto, Yu, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Sakurai, Takatoshi, Yagihashi, Akinori, Takahagi, Shusaku, Iwabuchi, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699084/ http://dx.doi.org/10.1093/noajnl/vdaa143.102 |
Ejemplares similares
-
COT-12 Clinical feature of end-stage glioblastomas
por: Saito, Norihiko, et al.
Publicado: (2021) -
Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model
por: Saito, Norihiko, et al.
Publicado: (2019) -
CBMS-03 PHOSPHORYLATION STATE OF OLIG2 REGULATES PROLIFERATION OF GLIOMA STEM CELLS
por: Saito, Norihiko, et al.
Publicado: (2019) -
NQPC-15 DEVELOPMENT OF BRAIN TUMOR SURVIVORSHIP PROGRAM
por: Saito, Norihiko, et al.
Publicado: (2022) -
The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2019)